Abstract
Introduction
Testosterone (T) is a hormone that is crucial for primary and secondary sexual development in both males and females. Free testosterone (FT) represents the biologically active form of T, and its measurement is of great importance in clinical practice. While application of either equilibrium dialysis or ultrafiltration is considered to be the gold standard for FT assessment, these methods are expensive and not widely accessible. As an alternative, the Vermeulen formula is a commonly utilized calculated method.
Methods
This clinical study, including 190 consecutive patients, was carried out to compare FT levels obtained through direct immunoluminometric assay and the Vermeulen formula. The comparison was performed using Passing-Bablok and Deming regression as well as the Bland–Altman plot. Sensitivity, specificity, accuracy, positive predictive value, and negative predictive value were assessed.
Results
The calculated method employing the Vermeulen formula was considered the gold standard. Passing-Bablok regression indicated a good agreement between the two methods, with slopes close to 1 for the whole series. Although the Bland–Altman plot demonstrated overall agreement, a potential proportional bias was observed in females. Deming regression confirmed excellent agreement and reliable estimates. Sensitivity and specificity analysis revealed that the direct method had a sensitivity of 75.0% and a specificity of 93.4% in all patients. However, sensitivity improved to 81.0% in males and dropped to 18.2% in females likely due to the low number of true positive cases.
Conclusion
The direct method exhibited comparable performance to the calculated method, but caution should be exercised when interpreting results, particularly in females. Further studies are necessary to validate its sensitivity and specificity in larger series.
Similar content being viewed by others
References
Kelly DM, Jones TH (2013) Testosterone: a metabolic hormone in health and disease. J Endocrinol 217(3):R25-45
Rastrelli G, Corona G, Maggi M (2018) Testosterone and sexual function in men. Maturitas 112:46–52
McHenry J, Carrier N, Hull E, Kabbaj M (2014) Sex differences in anxiety and depression: role of testosterone. Front Neuroendocrinol 35(1):42–57
Sharma A, Minhas S, Dhillo WS, Jayasena CN (2021) Male infertility due to testicular disorders. J Clin Endocrinol Metab 106(2):e442–e459
Oduwole OO, Huhtaniemi IT, Misrahi M (2021) The roles of luteinizing hormone, follicle-stimulating hormone and testosterone in spermatogenesis and folliculogenesis revisited. Int J Mol Sci 22(23):12735
Rajfer J (2000) Relationship between testosterone and erectile dysfunction. Rev Urol 2(2):122–128
Kloner RA, Carson C 3rd, Dobs A, Kopecky S, Mohler ER 3rd (2016) Testosterone and cardiovascular disease. J Am Coll Cardiol 67(5):545–557
Bhasin S, Valderrábano RJ, Gagliano-Jucá T. Age-related changes in the male reproductive system. In: Feingold KR, Anawalt B, Blackman MR, et al., eds. Endotext. South Dartmouth (MA): MDText.com, Inc.; February 10, 2022
Linderman JK, O’Hara R, Ordway J (2020) Effect of special operations training on testosterone, lean body mass, and strength and the potential for therapeutic testosterone replacement: a review of the literature. J Spec Oper Med 20(1):94–100
Khodamoradi K, Khosravizadeh Z, Seetharam D, Mallepalli S, Farber N, Arora H (2022) The role of leptin and low testosterone in obesity. Int J Impot Res 34(7):704–713
Corona G, Vena W, Pizzocaro A, Giagulli VA, Francomano D, Rastrelli G, Mazziotti G, Aversa A, Isidori AM, Pivonello R, Vignozzi L, Mannucci E, Maggi M, Ferlin A (2022) Testosterone supplementation and bone parameters: a systematic review and meta-analysis study. J Endocrinol Invest 45(5):911–926
Corona G, Guaraldi F, Rastrelli G, Sforza A, Maggi M (2021) Testosterone deficiency and risk of cognitive disorders in aging males. World J Mens Health 39(1):9–18
Pintana H, Chattipakorn N, Chattipakorn S (2015) Testosterone deficiency, insulin-resistant obesity and cognitive function. Metab Brain Dis 30(4):853–876
Davis SR, Wahlin-Jacobsen S (2015) Testosterone in women–the clinical significance. Lancet Diabetes Endocrinol 3(12):980–992
Smith T, Batur P (2021) Prescribing testosterone and DHEA: the role of androgens in women. Cleve Clin J Med 88(1):35–43
Le J, Thomas N, Gurvich C (2020) Cognition, the menstrual cycle, and premenstrual disorders: a review. Brain Sci 10(4):198
Stanczyk FZ (2006) Diagnosis of hyperandrogenism: biochemical criteria. Best Pract Res Clin Endocrinol Metab 20(2):177–191
Goldman AL, Bhasin S, Wu FCW, Krishna M, Matsumoto AM, Jasuja R (2017) A reappraisal of testosterone’s binding in circulation: physiological and clinical implications. Endocr Rev 38(4):302–324
Vermeulen A (1973) Testosterone in plasma. A physiopathological study. Verh - Geneeskd Belg 35:95–180
Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA (2018) Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 103(5):1715–1744
Isidori AM, Aversa A, Calogero A, Ferlin A, Francavilla S, Lanfranco F, Pivonello R, Rochira V, Corona G, Maggi M (2022) Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE). J Endocrinol Invest 45(12):2385–2403
Vermeulen A (2005) Hormonal cut-offs of partial androgen deficiency: a survey of androgen assays. J Endocrinol Invest 28(3 Suppl):28–31
Plebani M (2006) Errors in clinical laboratories or errors in laboratory medicine? Clin Chem Lab Med 44(6):750–759
Casagrande A, Fabris F, Girometti R (2020) Beyond kappa: an informational index for diagnostic agreement in dichotomous and multivalue ordered-categorical ratings. Med Biol Eng Comput 58(12):3089–3099
Fiers T, Wu F, Moghetti P, Vanderschueren D, Lapauw B, Kaufman JM (2018) Reassessing free-testosterone calculation by liquid chromatography-tandem mass spectrometry direct equilibrium dialysis. J Clin Endocrinol Metab 103(6):2167–2174
Kacker R, Hornstein A, Morgentaler A (2013) Free testosterone by direct and calculated measurement versus equilibrium dialysis in a clinical population. Aging Male 16(4):164–168
Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H (2007) Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 92(2):405–413
Matsumoto AM, Bremner WJ (2004) Serum testosterone assays–accuracy matters. J Clin Endocrinol Metab 89(2):520–524
Tosi F, Fiers T, Kaufman JM, Dall’Alda M, Moretta R, Giagulli VA, Bonora E, Moghetti P (2016) Implications of androgen assay accuracy in the phenotyping of women with polycystic ovary syndrome. J Clin Endocrinol Metab 101(2):610–618
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
The study was conducted in accordance with the Declaration of Helsinki.
Informed consent
The FT evaluation was part of patient diagnostic routine for which patients signed informed consent.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Dalmiglio, C., Bombardieri, A., Mattii, E. et al. Analytical performance of free testosterone calculated by direct immunoluminometric method compared with the Vermeulen equation: results from a clinical series. Hormones (2024). https://doi.org/10.1007/s42000-023-00522-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s42000-023-00522-x